Antiviral Activity of Acetylsalicylic Acid against Bunyamwera Virus in Cell Culture
Viruses · 2023
DOI: 10.3390/v15040948 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Sara Yolanda Fernández-Sánchez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cell Structure Laboratory, Centro Nacional de Biotecnología, CSIC, Campus de Cantoblanco, 28049 Madrid, Spain. Hauptthemen laut MEDLINE: Bunyamwera virus, Orthobunyavirus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Spanish Ministry of Science and Innovation.
Abstract (Originalsprache)
The Bunyavirales order is a large group of RNA viruses that includes important pathogens for humans, animals and plants. With high-throughput screening of clinically tested compounds we have looked for potential inhibitors of the endonuclease domain of a bunyavirus RNA polymerase. From a list of fifteen top candidates, five compounds were selected and their antiviral properties studied with Bunyamwera virus (BUNV), a prototypic bunyavirus widely used for studies about the biology of this group of viruses and to test antivirals. Four compounds (silibinin A, myricetin, L-phenylalanine and p-aminohippuric acid) showed no antiviral activity in BUNV-infected Vero cells. On the contrary, acetylsalicylic acid (ASA) efficiently inhibited BUNV infection with a half maximal inhibitory concentration (IC50) of 2.02 mM. In cell culture supernatants, ASA reduced viral titer up to three logarithmic units. A significant dose-dependent reduction of the expression levels of Gc and N viral proteins was also measured. Immunofluorescence and confocal microscopy showed that ASA protects the Golgi complex from the characteristic BUNV-induced fragmentation in Vero cells. Electron microscopy showed that ASA inhibits the assembly of Golgi-associated BUNV spherules that are the replication organelles of bunyaviruses. As a consequence, the assembly of new viral particles is also significantly reduced. Considering its availability and low cost, the potential usability of ASA to treat bunyavirus infections deserves further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cell Structure Laboratory, Centro Nacional de Biotecnología, CSIC, Campus de Cantoblanco, 28049 Madrid, Spain.
- Centro Universitario de la Defensa, Universidad Politécnica de Cartagena, C/Coronel López Peña s/n, Base Aérea de San Javier, Santiago de la Ribera, 30720 Murcia, Spain.
ORCID-Profile: José P Cerón-Carrasco, Cristina Risco, Isabel Fernández de Castro
Förderung
- Spanish Ministry of Science and Innovation
Zitieren
APA
Fernández-Sánchez, S. Y., Cerón-Carrasco, J. P., Risco, C., & Fernández de Castro, I. (2023). Antiviral Activity of Acetylsalicylic Acid against Bunyamwera Virus in Cell Culture. Viruses. https://doi.org/10.3390/v15040948
Vancouver
Fernández-Sánchez SY, Cerón-Carrasco JP, Risco C, Fernández de Castro I. Antiviral Activity of Acetylsalicylic Acid against Bunyamwera Virus in Cell Culture. Viruses. 2023. doi:10.3390/v15040948
BibTeX
@article{FernndezSnchez2023,
author = {Fernández-Sánchez, Sara Yolanda and Cerón-Carrasco, José P and Risco, Cristina and Fernández de Castro, Isabel},
title = {Antiviral Activity of Acetylsalicylic Acid against Bunyamwera Virus in Cell Culture},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15040948}
}
EUVIMED